1.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
by Powles, Thomas
The lancet oncology, 2021, Vol.22 (7), p.931-945
Filter electronic articles 1 Hits
Remove Filters
- Subjects
- Carboplatin
- Cancer Therapies (1)
- Cancer (1)
- more ...
- Antineoplastic Combined Chemothe... (1)
- Carboplatin - Therapeutic Use (1)
- Carcinoma (1)
- Carcinoma - Mortality (1)
- Carcinoma - Immunology (1)
- Carcinoma - Drug Therapy (1)
- Antineoplastic Combined Chemothe... (1)
- Antineoplastic Agents, Immunolog... (1)
- Antibodies
- Analysis (1)
- Aged (1)
- Antibodies, Monoclonal, Humanize... (1)
- Antibodies, Monoclonal, Humanize... (1)
- Antineoplastic Agents, Immunolog... (1)
- Antineoplastic Agents (1)
- Antimitotic Agents (1)
- Adverse Events (1)
- less ...